156 related articles for article (PubMed ID: 16398716)
1. Management of the well renal transplant recipient: outpatient surveillance and treatment recommendations.
Salifu MO; Tedla F; Markell MS
Semin Dial; 2005; 18(6):520-8. PubMed ID: 16398716
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression and immune monitoring after renal transplantation.
Zand MS
Semin Dial; 2005; 18(6):511-9. PubMed ID: 16398715
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up and complications after cardiac transplantation.
Conrad SA; Chhabra A; Vay D
J La State Med Soc; 1993 May; 145(5):217-20, 223-5. PubMed ID: 8340685
[TBL] [Abstract][Full Text] [Related]
4. [Immune monitoring of kidney transplant recipients: can markers predictive of over-immunosuppression be identified?].
Saas P; Courivaud C; Bamoulid J; Garnache-Ottou F; Seilles E; Ducloux D
Ann Pharm Fr; 2008 Mar; 66(2):115-21. PubMed ID: 18570910
[TBL] [Abstract][Full Text] [Related]
5. Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients.
Ho WL; Murphy GM
Br J Dermatol; 2008 Feb; 158(2):217-24. PubMed ID: 18070205
[TBL] [Abstract][Full Text] [Related]
6. [Transplant patient monitoring].
Caillard S; Moulin B
Rev Prat; 2007 Feb; 57(3):299-308. PubMed ID: 17578031
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for outpatient monitoring of kidney transplant recipients.
Hariharan S
Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S22-36. PubMed ID: 16567238
[TBL] [Abstract][Full Text] [Related]
8. [Current status and development of kidney transplantation].
Kirste G
Zentralbl Chir; 1993; 118(3):113-7. PubMed ID: 8484282
[TBL] [Abstract][Full Text] [Related]
9. The impact of employment status on recipient and renal allograft survival.
Petersen E; Baird BC; Barenbaum LL; Leviatov A; Koford JK; Shihab F; Goldfarb-Rumyantzev AS
Clin Transplant; 2008; 22(4):428-38. PubMed ID: 18312443
[TBL] [Abstract][Full Text] [Related]
10. A delicate balance: negotiating renal transplantation, immunosuppression and adherence to medical regimen.
Cook PS; McCarthy A
Health (London); 2007 Oct; 11(4):497-512. PubMed ID: 17855470
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
[TBL] [Abstract][Full Text] [Related]
12. The Bergamo Kidney Transplant Program.
Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
[TBL] [Abstract][Full Text] [Related]
13. The natural course of cytomegalovirus infection and disease in renal transplant recipients.
Hartmann A; Sagedal S; Hjelmesaeth J
Transplantation; 2006 Jul; 82(2 Suppl):S15-7. PubMed ID: 16858268
[TBL] [Abstract][Full Text] [Related]
14. Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation.
Hamer RA; Chow CL; Ong AC; McKane WS
Transplantation; 2007 Jan; 83(1):36-40. PubMed ID: 17220788
[TBL] [Abstract][Full Text] [Related]
15. Predictors of new onset diabetes after renal transplantation.
Joss N; Staatz CE; Thomson AH; Jardine AG
Clin Transplant; 2007; 21(1):136-43. PubMed ID: 17302602
[TBL] [Abstract][Full Text] [Related]
16. General health management and long-term care of the renal transplant recipient.
Cohen D; Galbraith C
Am J Kidney Dis; 2001 Dec; 38(6 Suppl 6):S10-24. PubMed ID: 11729002
[TBL] [Abstract][Full Text] [Related]
17. Issues of obesity in kidney transplantation.
Kent PS
J Ren Nutr; 2007 Mar; 17(2):107-13. PubMed ID: 17321949
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous kidney-pancreas transplantation: the Parma Center experience.
Capocasale E; Busi N; Mazzoni MP; Valle RD; Maggiore U; Bignardi L; Buzio C; Sianesi M
Acta Biomed; 2007 Aug; 78(2):123-7. PubMed ID: 17936944
[TBL] [Abstract][Full Text] [Related]
19. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
20. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
Porrini E; Delgado P; Alvarez A; Cobo M; Pérez L; González-Posada JM; Hortal L; Gallego R; García JJ; Checa M; Morales A; Salido E; Hernández D; Torres A
Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
